Instructions for Novathenol (dexpanthenol) ointment
English product name
D-Panthenol Novathenol
Release Form dexpanthenol
cream d/external approx. 5% (50 mg/1 g): tubes 25 g 1 pcs or 50 g 1 or 2 pcs
ointment d/external approx. 5% (50 mg/1 g): tubes 25 g 1 pcs or 50 g 1 or 2 pcs
Description
The cream for external use is homogeneous, white in color, with a specific smell.
1g
dexpantenol 50 mg
Auxiliary substances: macrogol cetostearyl ether A6, macrogol cetostearyl ether A25, cetylstearyl 2-ethylhexanoate, cetyl alcohol, dimethicone, glycerol monostearate 40-55 (type II), propylene glycol, methylparahydroxybenzoate, propyl parahydroxybenzoate, aromatizator, water purified.
25 g - aluminium tubes (1) - cardboard packs.
50 g - aluminium tubes (1) - cardboard packs.
50 g - aluminium tubes (2) - cardboard packs
ATC codes
D03AX03 Dexpanthenol
Clinical-pharmacological groups / Group affiliation
Preparation for improving tissue trophic and regeneration for external use
Active substance
dexpantenol
Pharmaco-therapeutic group Novathenol
Tissue regeneration stimulant
Storage Conditions
The drug should be stored in a place inaccessible to children at a temperature not higher than 25 ° C.
Best before date
The shelf life is two years. Do not use after expiry date.
Pharmacological effect dexpanthenol
Dexaminol is a pantothenic acid derivative that is an integral part of Coenzyme A and is involved in acetylation, carbohydrate and fat metabolism, acetylcholine synthesis, steroid hormones, and porphyrins. It stimulates skin regeneration, normalizes cellular metabolism, accelerates mitosis and increases collagen fiber strength. It has regenerating, metabolic and mild anti-inflammatory effects.
The increased need for pantothenic acid is observed when skin or tissue damage occurs, in which case the local pantothenic acid deficiency can be remedied by local use of D-Panthenol Novatenol.
The optimal molecular mass of dexpantenol, hydrophilicity and low polarity make it possible for active substances to penetrate all layers of the skin.
The adjuvants that make up the D-Panthenol Novatenol cream improve its properties.
Testimony Novathenol
Cream
Mild skin damage caused by mechanical, chemical, temperature and other factors:
scratches, abrasions;
irritation after exposure to ultraviolet (including solar) and x-ray radiation;
Burns of various origins (including sunburns);
dermatitis;
Prevention and treatment of mild pelenoid dermatitis in young children;
Prevention and treatment of breast nipple cracks in nursing mothers;
Protection of the skin against adverse climatic factors (weathering and frostbite);
Prevention and treatment of mild diseases in children and adults;
skin treatment around tracheoste, gastrost and coloste.
Method of use, course and dosage Novathenol
Cream or ointment is applied in a thin layer on the affected area, rubbing slightly, two - four times a day (if necessary, more often). If applied to the infected skin surface, it should be treated with an antiseptic.
Nursing mothers are smeared with an ointment after each feeding.
For babies (including newborns), an ointment or cream is applied after each change of clothes or water treatment.
- dexpanthenol Nosology (ICD codes)
- L02
- Skin abscess, boils and carbuncles
- L20.8
- Other atopic dermatitis (neurodermatitis, eczema)
- L22
- Diaper dermatitis
- L23
- Allergic contact dermatitis
- L24
- Simple Irritable [irritant] Contact Dermatitis
- L28.0
- Simple chronic lychee (limited neurodermatitis)
- L30.4
- Erythematosus
- L30.9
- Dermatitis unspecified
- L55
- Sunburn
- L56.2
- Photo Contact Dermatitis [berloque dermatitis]
- L58
- Radiation dermatitis radionuclium
- L89
- Decubital ulcer and pressure area
- L98.4
- Chronic skin ulcer not classified in other categories
- N64.0
- Crack and Fistula Nipple
- R23
- Other skin changes
- T14.0
- Superficial injury of an unspecified area of the body (including abrasion, bruising, bruising, hematoma, bite of a non-venomous insect)
- T14.1
- Open wound of unspecified body region
- T30
- Thermal and chemical burns of unspecified location
- T33
- Surface frostbite
- Z58.8
- Other challenges related to physical environmental factors
- Z93.0
- Presence of tracheostoma
- Z93.1
- Availability of gastrostomas
- Z93.3
- Presence of colostomy
- Z94.5
- Presence of transplanted skin, autogenous skin graft
